Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Nature Reviews. Clinical Oncology|April 23, 2014
Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.
Neurobiology of Aging|February 23, 2013
Variation in tau isoform expression in different brain regions and disease statesElisa Majounie, William Cross, Victoria Newsway, et al.
Nature Reviews. Clinical Oncology|September 13, 2017
Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.
Nature Communications|February 27, 2020
Measuring single cell divisions in human tissues from multi-region sequencing dataBenjamin Werner, Jack Case, Marc J Williams, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT TrialPeter Meidahl Petersen, Adrian D Cook, Matthew R Sydes, et al.
Journal of Bone Oncology|September 30, 2020
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert groupJanet E Brown, Catherine Handforth, Juliet E Compston, et al.
Communicable Diseases Intelligence (2018)|March 24, 2025
Prevalence of Murray Valley encephalitis virus antibodies in northern Victoria following the 2023 outbreak: a cross-sectional serological surveyMarie Heloury, Joshua Szanyi, Maxwell Braddick, et al.
Genome Medicine|August 30, 2022
A genetic model for central chondrosarcoma evolution correlates with patient outcomeWilliam Cross, Iben Lyskjær, Tom Lesluyes, et al.
Nature Communications|April 6, 2016
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapyJohn M Findlay, Francesc Castro-Giner, Seiko Makino, et al.
Plos One|June 2, 2022
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial dataCaroline S Clarke, Rachael M Hunter, Andrea Gabrio, et al.
Pageof 7